BIOHLDG 0.030 (0.00%) | BIOALPHA HOLDINGS BERHAD

BIOHLDG | BIOALPHA HOLDINGS BERHAD

0.030 (0.0%)

T-O (am): 0.000 (08:59:00)
Last updated: 16:50

Fundamental

Technical

Total Score

BIOHLDG Support & Resistance

ATR Trailing Stop: 0.03

	Support		Last Price	Resistance
Price	0.025	0.03	0.03	0.03	0.04	0.045	0.06	0.065
Volume (M)	14.4	10.2		10.2	6.5	6.2	105.5	94.8

Gann Support: 0.03 | Resistance: 0.04/0.05

*Highlighted column shows significant volume at the support or resistance area.

BIOHLDG Technical Trend

BIOHLDG Trading Signals

Based on iSaham Screeners

Moving Average (Short Term)
Moving Average (Mid Term)
Moving Average (Long Term)
Ichimoku Kumo
Bollinger Band
RSI
Stochastic
Heikin-Ashi
MACD
Solid MA Trend
SAT

Sector Trend (Long Term)
Sector Trend (Short Term)
Institutional Holdings
Beat The Insti
Magic Formula
Better Than ASB
52-Week High
BTST
T+
Candlestick
Chart Pattern

Please be fully informed regarding the risks and costs associated with trading in the stock markets. Any trade you made must be followed by your own judgement and analysis. Please read our risk disclosure for more info.

BIOHLDG Pivot Point

	S2	S1	P	R1	R2
Daily	0.025	0.025	0.03	0.03	0.035
Weekly	0.025	0.025	0.03	0.03	0.035

BIOHLDG Fundamental Trend

FCON: | Sharpe Ratio: | LTS:

BIOHLDG Quarter Reports

Customize

Ann. Date	Qtr. Date	Q	FYE	Revenue [M]	PBT [M]	NP [M]	NPM	EPS	R. QoQ	R. YoY	E. QoQ	E. YoY
28 Feb 25	Q4 Dec 24	4	31 Dec 24	17.12	-23.86	-22.76	-132.9%	-1.62	51.0%	1.1%	306.6%	49.1%
29 Nov 24	Q3 Sep 24	3	31 Dec 24	34.93	-6.31	-5.60	-16.0%	-0.40	52.1%	198.1%	24.4%	155.1%
30 Aug 24	Q2 Jun 24	2	31 Dec 24	22.96	-7.83	-7.41	-32.2%	-0.53	217.9%	169.7%	6.0%	119.7%
31 May 24	Q1 Mar 24	1	31 Dec 24	7.22	-7.26	-6.99	-96.8%	-0.50	58.3%	15.3%	54.2%	59.2%
29 Feb 24	Q4 Dec 23	4	31 Dec 23	17.32	-16.85	-15.26	-88.1%	-1.09	47.8%	56.3%	595.7%	44.8%
30 Nov 23	Q3 Sep 23	3	31 Dec 23	11.72	-2.71	-2.19	-18.7%	-0.17	37.7%	61.3%	34.9%	68.2%
30 Aug 23	Q2 Jun 23	2	31 Dec 23	8.51	-3.58	-3.37	-39.6%	-0.27	0.2%	10.0%	80.3%	55.7%
31 May 23	Q1 Mar 23	1	31 Dec 23	8.53	-17.31	-17.11	-200.6%	-1.36	23.0%	11.7%	38.1%	327.7%
28 Feb 23	Q4 Dec 22	4	31 Dec 22	11.08	-28.47	-27.66	-249.6%	-2.01	52.5%	19.7%	301.3%	375.4%

BIOHLDG Historical Dividends

BIOHLDG Financial Ratios

EPS	-3.04 sen
Trailing PE (Sector Median: 15.3)	0.0
PEG	0.0
Altman Z	0.0
Beaver	0.013
Current Ratio	2.33
Debt-Equity (DE) Ratio	0.29
FCF Yield	-1.78 %

Revenue QoQ	-50.98 %
Revenue YoY	-1.13%
Profit QoQ	-306.63 %
Profit YoY	-49.1 %
Profit Margin (Sector Median: 5.0)	-51.98 %
ROE (ROIC: -19.84)	-19.97 %
Dividend Per Share (DPS)	0.0 sen
Dividend Yield (DY)	0.0 %

BIOHLDG Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 15.3)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 5.0)
ROE (ROIC: -19.92)
Altman Z

BIOHLDG Fair Value

Weighted Average Fair Value:

Discounted Cash Flow (DCF)^{5% Growth}
Discounted Cash Flow (DCF)^{10% Growth}
Relative Valuation

Graham Formula
Graham Number
Net Tangible Asset (NTA)	0.07
Consistent QR FV

The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator Growth/Risk FV Calculator Contract Value Calculator Profit-Based Calculator Revenue-Based Calculator

Forward PE FV Calculator
Latest Profit (adjusted) [M]	-22.76
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value

Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value

Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value

Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value

Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value

Market Pricing
Expected Profit (M)	0.0
Expected Revenue (M)	0.0
Expected Growth (%)	0.0

The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

BIOHLDG Directors Share Purchases (Beta)

MR HON TIAN KOK @ WILLIAM added 90807.0 units announced on 30 Jun 2023 at ~RM0.09

MR HON TIAN KOK @ WILLIAM reduced 8775100.0 units announced on 22 Jul 2022 at ~RM0.13

MR HON TIAN [email protected] reduced 9335200.0 units announced on 14 Jul 2022 at ~RM0.135

MR HON TIAN [email protected] reduced 4931000.0 units announced on 08 Jul 2022 at ~RM0.13

MR HON TIAN [email protected] reduced 6206300.0 units announced on 01 Jul 2022 at ~RM0.145

MISS GOH SIOW CHENG reduced 3071600.0 units announced on 01 Jul 2022 at ~RM0.145

MISS GOH SIOW CHENG reduced 4928400.0 units announced on 29 Jun 2022 at ~RM0.15

MR HO TZE HIUNG reduced 8000000.0 units announced on 27 Jun 2022 at ~RM0.155

MR HON TIAN KOK @ WILLIAM added 8070900.0 units announced on 13 May 2022 at ~RM0.135

MR HON TIAN KOK @ WILLIAM added 3579200.0 units announced on 12 May 2022 at ~RM0.135

MR HON TIAN KOK @ WILLIAM added 1850000.0 units announced on 11 May 2022 at ~RM0.13

MR HON TIAN KOK @ WILLIAM added 1500000.0 units announced on 16 Mar 2022 at ~RM0.135

MR HON TIAN KOK @ WILLIAM added 13440735.0 units announced on 04 Mar 2022 at ~RM0.15

MR HON TIAN KOK @ WILLIAM added 138400.0 units announced on 29 Dec 2021 at ~RM0.185

MR HON TIAN [email protected] added 1866733.0 units announced on 05 Aug 2021 at ~RM0.21

MR HON TIAN [email protected] added 1000000.0 units announced on 10 Dec 2020 at ~RM0.285

ENCIK MOHD NASIR BIN ABDULLAH reduced 100000.0 units announced on 12 Nov 2020 at ~RM0.255

MOHD NASIR BIN ABDULLAH reduced 200000.0 units announced on 25 Aug 2020 at ~RM0.31

MR HO TZE HIUNG reduced 1000000.0 units announced on 03 Aug 2020 at ~RM0.285

BIOHLDG Summary

Market Cap: 42 M.

Market Cap Class: Shrimp

Number of Shares: 1406 M.

Adjusted Float: 67.0%.

Stock highly correlated with

SAMCHEM (92%)

GENTING (91%)

N2N (89%)

ASIAFLE (88%)

Bioalpha Holdings Berhad, incorporated in 2011 and headquartered in Kajang, Malaysia, is an integrated health supplement company specializing in the manufacturing, distribution, and retailing of nutraceutical and functional food products. The company operates across the entire value chain, encompassing herbal cultivation, research and development (R&D), manufacturing, trading, and retail pharmacy operations under the Constant Pharmacy brand. Bioalpha’s product portfolio includes herbal and non-herbal health supplements, functional foods, and traditional medicines, produced under both original design manufacturing (ODM) and proprietary house brands. The company also engages in herbal farming, operating MyGAP-certified herbal parks in Terengganu and Johor to ensure a stable supply of raw materials. Expanding regionally, Bioalpha has established a strong presence in Malaysia, Indonesia, and China, leveraging strategic partnerships, sustainable sourcing, and digital transformation initiatives. With a commitment to quality, innovation, and ESG-driven strategies, Bioalpha Holdings Berhad continues to strengthen its position in the health and wellness industry across key markets.

Sectors: Penny Stocks, Trading & Services, Food & Beverages, Consumer Products & Services

Share Registrar: PROSEC SHARE REGISTRATION SDN. BHD.

Code: 0179

Website: http://www.bioa.com.my/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

Symbol	Price	Ex.Price	Premium	Expiry
BIOHLDG-WB	0.01	0.1	266.67%	05-Feb-2027

BIOHLDG Top Shareholdings

Updated on 31-Mar-2023

Shareholder	%	Value (M)
Finexia Securities Ltd	10.89%	4.6
Perbadanan Nasional Berhad	8.77%	3.7
Malaysian Technology Development Corporation	8.3%	3.5
Sanston Financial Group Ltd	5.16%	2.18
Ooi Keng Thye	5.08%	2.14
iCapital.Biz Berhad	3.56%	1.5
Hon Tian Kok @ William	3.27%	1.38
Perusahaan Saudee Sdn Bhd	2.4%	1.01
Ace Edible Oil Industries Sdn Bhd	2.2%	0.93
Lazarus Securities PTY Ltd	1.74%	0.73
The Hongkong And Shanghai Banking Corporation Ltd	1.66%	0.7
Morgan Stanley & Co International Plc	0.89%	0.38
Cheng Chew Giap	0.8%	0.34
Ho Huey Chuin	0.75%	0.32
Seah Tin Kim	0.67%	0.28
Ong Keng Seng	0.55%	0.23
Khor Hsia Joew	0.47%	0.2
Capital Dynamics Asset Management Sdn Bhd	0.39%	0.16
Voon Sze Lin	0.31%	0.13
Yung Boon Hong @ Yang Kok Ching	0.3%	0.13
Goh Kuang Wei	0.29%	0.12
Tan Han Chong	0.25%	0.11
Kua Hock Lai	0.23%	0.1
Tan Tio Cheng @ Tan Chow Cheng	0.22%	0.09
Lim Choon Eek	0.2%	0.08
Aw Kheng Tong	0.2%	0.08
Vani A/P Subramaniam	0.2%	0.08
Chong Kwee Siong	0.19%	0.08
Chen Yoon Fong	0.19%	0.08

Net Cost Calculator Lot Calculator

This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.

BIOHLDG | BIOALPHA HOLDINGS BERHAD

0.030 (0.0%)

BIOHLDG Support & Resistance

ATR Trailing Stop: 0.03

Gann Support: 0.03 | Resistance: 0.04/0.05

*Highlighted column shows significant volume at the support or resistance area.

BIOHLDG Technical Trend

BIOHLDG Trading Signals

Based on iSaham Screeners

BIOHLDG Pivot Point

BIOHLDG Fundamental Trend

FCON: | Sharpe Ratio: | LTS:

Chart:

BIOHLDG Quarter Reports

BIOHLDG Historical Dividends

BIOHLDG Financial Ratios

BIOHLDG Adjusted Financial Ratios

BIOHLDG Fair Value

Weighted Average Fair Value:

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

BIOHLDG Directors Share Purchases (Beta)

BIOHLDG Summary

Warrant Info:

BIOHLDG Top Shareholdings

Features

Services

Others

Company

BIOHLDG | BIOALPHA HOLDINGS BERHAD

0.030 (0.0%)

BIOHLDG Support & Resistance

ATR Trailing Stop: 0.03

Gann Support: 0.03 | Resistance: 0.04/0.05

*Highlighted column shows significant volume at the support or resistance area.

BIOHLDG Technical Trend

BIOHLDG Trading Signals

Based on iSaham Screeners

BIOHLDG Pivot Point Click to learn about Pivot Point

BIOHLDG Fundamental Trend

FCON: This feature is limited for iSaham Pro only | Sharpe Ratio: This feature is limited for iSaham Pro only | LTS: This feature is limited for iSaham Pro only

Chart:

BIOHLDG Quarter Reports

BIOHLDG Historical Dividends

BIOHLDG Financial Ratios

BIOHLDG Adjusted Financial Ratios

BIOHLDG Fair Value

Weighted Average Fair Value: This feature is limited for iSaham Pro only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

BIOHLDG Directors Share Purchases (Beta)

BIOHLDG Summary

Warrant Info:

BIOHLDG Top Shareholdings

BIOHLDG Pivot Point

FCON: | Sharpe Ratio: | LTS:

Weighted Average Fair Value: